Baseline characteristics of patients enrolled in the Arterio-Embolisation in Hemoptysis of Mild Severity trial of first-line bronchial artery embolisation or medical therapy alone for management of mild acute haemoptysis
| Variable | Medical strategy (n=38) | Interventional strategy (n=34) |
| Age (years) | 54.5 (44–69) | 51.0 (40–66) |
| Sex (male) | 26 (68.4) | 25 (73.5) |
| Current smokers* | 23 (60.5) | 23 (69.7) |
| Never smokers | 11 (28.9) | 7 (21.2) |
| Referral from | ||
| Home | 3 (7.9) | 1 (2.9) |
| Emergency department | 28 (73.7) | 22 (64.7) |
| Out-of-hospital emergency services | 4 (10.5) | 6 (17.6) |
| Hospital ward | 3 (7.9) | 5 (14.7) |
| Performance status† | ||
| 0 | 25 (89.3) | 25 (86.2) |
| 1 | 2 (7.1) | 2 (6.9) |
| 2 | 1 (3.6) | 1 (3.4) |
| 3 | 0 | 1 (3.4) |
| 4 | 0 | 0 |
| Pre-existing respiratory illness | ||
| At least one | 12 (31.6) | 13 (38.2) |
| Bronchiectasis | 4 (10.5) | 3 (8.8) |
| Lung cancer | 3 (7.9) | 1 (2.9) |
| Active tuberculosis | 2 (5.4) | 0 |
| Sequels of tuberculosis | 3 (7.9) | 7 (20.6) |
| Cardiovascular | ||
| Hypertension | 15 (39.5) | 9 (26.5) |
| Valvular disease | 1 (2.6) | 0 |
| Ischaemic heart disease | 1 (2.6) | 3 (8.8) |
| Clinical physiological data during the first 24 hours of admission (minimal and maximal values) | ||
| Core temperature (°C)‡ | 36.6 (36.2–36.8) | 36.6 (36.3–36.9) |
| 37.1 (37.0–37.4) | 37.1 (36.9–37.4) | |
| Heart rate (beats/min)§ | 66 (57–80) | 69 (61–79) |
| 88 (77–97) | 86 (72–95) | |
| Systolic blood pressure (mm Hg)¶ | 121 (105–134) | 125 (112–147) |
| 154 (138–171) | 160 (142–177) | |
| Respiratory rate (breaths/min)** | 15 (14–20) | 15 (14–20) |
| 23 (20–30) | 25 (22–31) | |
| Pulse oxymetry (%)†† | 96 (93–97) | 95 (93–97) |
| 99 (98–100) | 99 (97–100) | |
| Bleeding on admission and persistence | ||
| Cumulated bleeding amount on admission (mL)‡‡ | 120 (110–150) | 150 (120–150) |
| Persistent bloody expectoration after admission§§ | ||
| Laboratory data on admission | 34 (91.9) | 27 (93.1) |
| Platelet count (giga/L)¶¶ | 233 (195–256) | 219 (184–258) |
| Haemoglobin (g/dL)*** | 13.7 (12.2–15.0) | 14.0 (12.5–15.1) |
| Prothrombin time (%)††† | 95 (84–100) | 97 (89.5–100.0) |
| Blood urea nitrogen (mmol/L)‡‡‡ | 5 (4–6) | 5 (4–6) |
| Serum creatinine (μmol/L)§§§ | 67 (59–87) | 72 (64–1) |
Data are n (%) or median (IQR 25%–75%).
*Data are available for 71 patients (n1=38, n2=33).
†57 patients (n1=28, n2=29).
‡70 patients (n1=37, n2=33).
§71 patients (n1=38, n2=33).
¶70 patients (n1=37, n2=33).
**64 patients (n1=35, n2=29).
††68 patients (n1=36, n2=32).
‡‡71 patients (n1=38, n2=33).
§§66 patients (n1=37, n2=29).
¶¶70 patients (n1=37, n2=33).
***70 patients (n1=37, n2=33).
†††65 patients (n1=33, n2=32).
‡‡‡67 patients (n1=36, n2=31).
§§§70 patients (n1=37, n2=33).